A LONGITUDINAL, BIOMARKER STUDY OF ANTI-VEGF, TO EXPLORE THE RELATIONSHIP BETWEEN AQUEOUS HUMOR COMPOSITION AND MULTIMODAL RETINAL IMAGING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA
Latest Information Update: 20 Mar 2023
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Biomarker; Therapeutic Use
- Sponsors Roche
Most Recent Events
- 20 Mar 2023 This trial has been completed in Poland, according to European Clinical Trials Database record.
- 15 Mar 2023 This trial has been completed in Czechia, according to European Clinical Trials Database record.
- 16 Mar 2021 New trial record